News & Updates

Among commonly used antiseizure medications (ASMs), topiramate appears to result in weight loss at 6 and 12 months under either initiation and subsequent adherence or initiation-only effects, reports a study. Other ASMs seem to contribute to greater weight change.

New drug applications approved by US FDA as of 16-31 December 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

For Crohn’s disease (CD) patients with suboptimal response to ustekinumab, doubling the dosing frequency from every 8 weeks to every 4 weeks elicited meaningful improvements in objective and patient-reported outcomes, as shown in a small retrospective study.

A recent study suggests interventions for children to help them achieve their recommended sleep duration for weekdays and weekends and thus reduce abdominal and total adiposity, particularly in boys.

Timely screening is needed to enhance early detection of metabolic health, bone health, and hearing impairment among childhood cancer survivors treated in Singapore, suggests a recent study. Adoption of an exposure-based approach to proactively screen for late effects can reduce biopsychosocial impacts.

High maternal BMI prior to pregnancy appears to contribute to a BMI increase in their offspring during childhood, reveals a study. Moreover, preterm children are more likely to develop hypertension than their term counterparts.

For patients with irritable bowel syndrome (IBS), practicing yoga does not help improve symptoms, anxiety, depression, and quality of life, according to a systematic review and meta-analysis.